APP and neoplasm: Unexpectedly, the decrease rate of APP and ADAM10 has no difference between the experiment group and control group in tumour cell treatment with actinomycin D which was used to inhibit de novo transcription.13 These data showed that the effect of HuR‐regulated APP and ADAM10 levels was not through stabilizing APP and ADAM10 mRNA stability.